AgomAb Therapeutics NV: CEO Knotnerus Tim Jasper bought 11,000 shares

What happened

• Knotnerus Tim Jasper, CEO, purchased a total of 11,000 shares in two open-market transactions for a total of $94,380 ($50,880 and $43,500).

Key details

• Transaction dates and prices: Oct 5, 2026 — 6,000 shares at $8.48 ($50,880); Oct 6, 2026 — 5,000 shares at $8.70 ($43,500). (Transaction code: P = purchase.)
• Shares owned after the transaction: Not reported in the filing.
• Footnotes: F1 notes common shares may be represented by American Depositary Shares. F2 states shares held by TJK Life Sciences B.V.; the reporting person exercises voting and dispositive power over those shares and disclaims beneficial ownership except for any pecuniary interest.
• Filing date and timeliness: Filed on Oct 7, 2026; the filing does not indicate it was late.

Why it may matter

• The filing reports purchases by the CEO totaling 11,000 shares for $94,380.
• This filing does not show why the insider traded or why the company acted.